Catalyst Wire Dossier Catalyst Wire Dossier

Mometasone Furoate + Hydroquinone + Tretinoin combination cream

mometasone furoate 0.1%, hydroquinone 4%, tretinoin 0.05%
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mometasone Furoate + Hydroquinone + Tretinoin combination cream, covering 2025-01-17 to 2025-01-17. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Effectiveness and Safety of Triple Combination Cream of Fucinolone Acetonide 0.01%, Hydroquinone 4%, Tretinoin 0.05% with Mometasone Furoate 0.1%, Hydroquinone 4%, Tretinoin 0.05% in the Treatment of Melasma [NA]

See pricing